Cory Renauer
Cory Renauer is a contributing Motley Fool healthcare analyst covering pharmaceuticals, biotechnology, and medical devices. Previously, Cory was a laboratory technician for the American Red Cross. He holds a bachelor’s degree in biology from Oakland University.
Recent Articles by Cory Renauer

Jul 24, 2025
by Cory Renauer
Better Dividend Stock: Verizon vs. American Express

Jul 22, 2025
by Cory Renauer
2 Beaten-Down Dividend Growth Stocks to Buy on the Dip

Jul 22, 2025
by Cory Renauer
Meet the Biotech Stock That Rocketed 775% Higher
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.